Although leucovorin rescue is generally safe, improper administration can lead to suboptimal protection or interference with methotrexate's antitumor efficacy. Too early or too high doses of leucovorin may reduce the therapeutic effect of methotrexate, while insufficient doses may fail to prevent toxicity. Close monitoring and individualized dosage adjustments are essential to minimize these risks.
